XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
2.540
+0.120 (4.96%)
At close: Jun 18, 2026, 4:00 PM EDT
2.578
+0.038 (1.50%)
After-hours: Jun 18, 2026, 7:22 PM EDT
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of $5.75 million as of June 18, 2026. Its market cap has decreased by -48.22% in one year.
Market Cap
5.75M
Enterprise Value
5.55M
1-Year Change
-48.22%
Ranking
Category
Stock Price
$2.54
Market Cap Chart
Since September 1, 2005, XTL Biopharmaceuticals's market cap has decreased from $190.39M to $5.75M, a decrease of -96.98%. That is a compound annual growth rate of -15.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 5.79M | -18.66% |
| Dec 31, 2025 | 7.12M | -68.18% |
| Dec 31, 2024 | 22.38M | 322.69% |
| Dec 31, 2023 | 5.30M | -16.54% |
| Dec 29, 2022 | 6.35M | -57.67% |
| Dec 30, 2021 | 14.99M | -4.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genprex | 6.27M |
| BioAtla | 6.06M |
| AIM ImmunoTech | 5.98M |
| Soligenix | 5.92M |
| Cardio Diagnostics Holdings | 5.86M |
| Processa Pharmaceuticals | 5.83M |
| Evogene | 5.58M |
| Adial Pharmaceuticals | 5.57M |